Makio Gamoh

Phase II study of trastuzumab in combination with S-1 plus cisplatin in HER2-positive gastric cancer (HERBIS-1)

Yukinori Kurokawa, Naotoshi Sugimoto, Hiroto Miwa et al. · British Journal of Cancer · 2014 · 138 citations · Full text

Efficacy and Long-term Peripheral Sensory Neuropathy of 3 vs 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Colon Cancer

Takayuki Yoshino, Takeharu Yamanaka, Eiji Oki et al. · JAMA Oncology · 2019 · 96 citations · Full text

S-1 and irinotecan plus bevacizumab versus mFOLFOX6 or CapeOX plus bevacizumab as first-line treatment in patients with metastatic colorectal cancer (TRICOLORE): a randomized, open-label, phase III, noninferiority trial

Yasuhide Yamada, Tadamichi Denda, Makio Gamoh et al. · Annals of Oncology · 2017 · 86 citations · Full text

Oxaliplatin-based adjuvant chemotherapy duration (3 versus 6 months) for high-risk stage II colon cancer: the randomized phase III ACHIEVE-2 trial

Kentaro Yamazaki, Takeharu Yamanaka, Manabu Shiozawa et al. · Annals of Oncology · 2020 · 50 citations · Full text

Incidence of opioid‐induced constipation in Japanese patients with cancer pain: A prospective observational cohort study

Akihiro Tokoro, Hisao Imai, Soichi Fumita et al. · Cancer Medicine · 2019 · 42 citations · Full text